ReviewCaspian journal of internal medicine2025
A systematic review and meta-analysis of the prevalence of celiac disease in migraine patients.
Review in Caspian journal of internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Celiac disease (CD) is a gluten-induced autoimmune disorder that can present with gastrointestinal, extraintestinal, or no symptoms. The prevalence of CD in migraine patients and the nature of their potential association is not well established. Therefore, the purpose of this study was to investigate the prevalence of CD in migraine patients using a systematic review and meta-analysis. Methods: PRISMA guidelines created a framework for the construction of this review article. Two investigators independently searched the electronic databases of Scopus, PubMed, Web of Science and Google Scholar search engine up to May 2024. To assess heterogeneity among the studies, we used Cochran's Q test and the I² index. The statistical analyses were performed using Stata software, version 14.2, and a p-value of less than 0.05 was considered statistically significant. Results: This meta-analysis included a total of 6 articles, comprising 14,526 migraine patients. The overall prevalence of CD in migraine patients was estimated to be (2% (95% CI: 0%-5%, I Conclusions: Although the small amount of research accomplished in this particular situation, our data indicate a relatively low prevalence of CD in migraine patients. Therefore, more frequent and thorough research in this field is advised. Patients with migraines experienced fewer attacks when they received gluten-free diets and were screened for celiac disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.